FRSX
Foresight Autonomous Holdings Ltd.
There isn't enough reported data to score FRSX yet.
NKE
NIKE, Inc.
NKE's fundamentals are mixed, but it looks cheap: trading at 18x earnings, below its usual 33x. Analysts expect earnings to hold roughly steady, though they disagree widely on how much.
FRSX Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
FRSX's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
FRSX PE Valuation
FRSX has no meaningful PE right now: it lost money over the past year.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
FRSX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Decline | |
| -- | |
| Limited | |
| High |
Analysts expect FRSX's losses to grow, with revenue declining.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
FRSX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2025 | -$0.50 | +$0.35 |
| Q4 2024 | -$0.50 | +$0.76 |
| Q2 2024 | -$0.85 | +$3.50 |
| Q4 2023 | -$1.26 | +$7.20 |
| Q2 2023 | -$4.35 | +$3.33 |
| Q4 2022 | -$8.46 | -$3.00 |
| Q2 2022 | -$7.68 | -$1.38 |
| Q4 2021 | -$5.46 | +$3.36 |
FRSX is still losing money, but far less than before: $0.50 per share over the past year, against $21.42 at its worst in late 2017.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE has the edge over FRSX in the latest year-over-year earnings comparison.
FRSX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q4 2025 | $158K | -25% |
| Q2 2025 | $240K | +7.1% |
| Q4 2024 | $212K | -52% |
| Q2 2024 | $224K | +307% |
| Q4 2023 | $442K | +46% |
| Q2 2023 | $55K | -78% |
FRSX's revenue has slid since its 2023 peak: $158,000 last quarter, down 64% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2025 | -3789% | -2138 points |
| Q2 2025 | -2581% | +13775 points |
| Q4 2024 | -3097% | -172 points |
| Q2 2024 | -2728% | +749 points |
| Q4 2023 | -1650% | N/A |
| Q2 2023 | -16356% | N/A |
| Q4 2022 | -2925% | N/A |
| Q2 2022 | -3476% | N/A |
FRSX's operating margin was −3789% last quarter, down 2138 points from the same quarter a year ago.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE has the edge over FRSX in the latest year-over-year revenue comparison.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
FRSX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q4 2025 | -$5.1M | +$859K |
| Q2 2025 | -$5.4M | -$220K |
| Q4 2024 | -$6M | +$1M |
| Q2 2024 | -$5.2M | +$2.9M |
| Q4 2021 | -$6.5M | -$776K |
| Q2 2021 | -$5.8M | -$39K |
| Q4 2020 | -$5.8M | +$460K |
| Q2 2020 | -$5.8M | -$41K |
FRSX has burned cash in almost every quarter: −$22M over the past year, against −$27M the year before.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
FRSX Net Leverage
FRSX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
FRSX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 20.9 | Oversold |
| Stochastic | 6.7 | Oversold |
FRSX's weekly RSI is 21 (oversold) and its Stochastic is 7 (oversold).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
FRSX PE vs Consumer Cyclical Sector
FRSX has no meaningful PE right now: it lost money over the past year.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE is trading at 18x earnings, in line with the Consumer Cyclical sector's median of 18x.
FRSX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.82 | 30% below |
| 20 week MA | $1.12 | 49% below |
| 50 week MA | $2.16 | 74% below |
| 100 week MA | $7.77 | 93% below |
| 200 week MA | $21.1 | 97% below |
FRSX is in a downtrend: it's below all five of its weekly moving averages, and 97% below its 200-week average.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has the edge over FRSX on trend strength, trading above more of its moving averages.
FRSX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $132.3 | $632.5 | +378% |
| 2021 | $632.5 | $235.6 | -63% |
| 2022 | $235.6 | $64.3 | -73% |
| 2023 | $64.3 | $21.6 | -66% |
| 2024 | $21.6 | $38.6 | +79% |
| 2025 | $38.6 | $4.50 | -88% |
| 2026 YTD | $4.50 | $0.57 | -87% |
FRSX's yearly returns have swung widely, from +378% in 2020 to −88% in 2025. It's down 87% so far in 2026.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has the edge over FRSX on returns for 2026, with the stronger performance.